Seok-Joon Yoon

Seok-Joon Yoon

Auto-generated profile, based on publicly available information

Seok-Joon Yoon

Department of Family Medicine, Research Institute for Medical Science, Chungnam National University School of Medicine, Daejeon, Korea

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2014 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
SYSeok-Joon Yoon
Seok-Joon Yoon
JKJong-Sung Kim
Jong-Sung Kim
JJJin-Gyu Jung
Jin-Gyu Jung
SKSung-Soo Kim
Sung-Soo Kim
SKSamyong Kim
Samyong Kim

1 January 2014 in Korean Journal of Family Medicine
Verified
Journal Article
Open access
PDF file
CKChang-Gi Kim
Chang-Gi Kim
JKJong Sung Kim
Jong Sung Kim
JJJin-Gyu Jung
Jin-Gyu Jung
SKSung-Soo Kim
Sung-Soo Kim
SYSeok-Joon Yoon
Seok-Joon Yoon
HSHae-Sun Suh
Hae-Sun Suh
There needs to be an amendment to the Korean version of the Alcohol Use Disorder Identification Test (AUDIT) with regards to the recent change in percent alcohol by volume (ABV) Korean liquor. This study was performed to suggest a cutoff value, reliability and validity of AUDIT-Korean revised version (AUDIT-KR), which reflect the change of the ABV of Korean alcohol. The subjects were 435 peoples (210 males and 225 females), who visited the Chungnam National University Hospital for a comprehensive medical examination. The respondents completed the AUDIT-KR. At-risk drinking and alcohol use disorders had been evaluated by diagnostic interview. The Cronbach's alpha value, the receiver operating characteristic curve, the appropriate cutoff value, sensitivity and specificity of the AUDIT-KR were evaluated. There were 190 at-risk drinkers (111 males and 79 females), and 66 people with alcohol use disorders (48 males and 18 females). The cutoff value of the AUDIT-KR for at-risk drinking was 3 points (sensitivity 93.69% and specificity 78.79%) for males and 3 points (sensitivity 92.40% and specificity 78.08%) for females. The cutoff value for alcohol use disorders was 10 points (sensitivity 100.00% and specificity 89.51%) for males and 8 points (sensitivity 100.00% and specificity 93.71%) for females. Cronbach's alpha of the AUDIT-KR was 0.885. The above results suggest that the AUDIT-KR shows a high reliability and validity in identifying at-risk drinking and alcohol use disorders.

1 December 2018 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
SYSeok Joon Yoon
Seok Joon Yoon
SSSang-Yeon Suh
Sang-Yeon Suh
SKSun Hyun Kim
Sun Hyun Kim
JPJeanno Park
Jeanno Park
YKYu Jung Kim
Yu Jung Kim
DHDavid Hui
David Hui

1 January 2016 in Korean Journal of Family Medicine
Verified
Journal Article
Open access
PDF file
JCJung Wei Chang
Jung Wei Chang
JKJong Sung Kim
Jong Sung Kim
JJJin Gyu Jung
Jin Gyu Jung
SKSung Soo Kim
Sung Soo Kim
SYSeok Joon Yoon
Seok Joon Yoon
HJHak Sun Jang
Hak Sun Jang
Chang JW, et al. Korean J Fam Med. 2016 Nov;37(6):323-328. https://doi.org/10.4082/kjfm.2016.37.6.323

20 November 2013 in Alcohol, Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
JJJin‐Gyu Jung
Jin‐Gyu Jung
JKJong‐Sung Kim
Jong‐Sung Kim
YKYoung‐Seok Kim
Young‐Seok Kim
MOMi‐Kyeong Oh
Mi‐Kyeong Oh
SYSeok‐Joon Yoon
Seok‐Joon Yoon

1 January 2017 in Journal of Palliative Medicine
Verified
Journal Article
Closed access
SYSeok Joon Yoon
Seok Joon Yoon
SSSang-Yeon Suh
Sang-Yeon Suh
YLYong Joo Lee
Yong Joo Lee
JPJeanno Park
Jeanno Park
SHSunwook Hwang
Sunwook Hwang
KPKeon Uk Park
Keon Uk Park
Background: Objective Prognostic Score (OPS) was developed as an easy and simple prognosticating tool in South Korea. It has been validated retrospectively in a single center in South Korea. Objective: We aimed to validate the OPS prospectively for advanced cancer inpatients in South Korea using a multicenter study. Design: This was a prospective cohort study. Setting/Subjects: We enrolled 243 advanced cancer patients admitted in five palliative care units in South Korea from May 2013 till March 2015. Seven members of the Korean Palliative Medicine Research Network who are experts of palliative care led the study. Measurements: Clinical variables (dyspnea/anorexia/performance status) and laboratory variables (total leukocyte counts/serum total bilirubin/serum creatinine/lactate dehydrogenase) were collected at the enrollment. Survival time was calculated as days from enrollment to death during admission. Results: A total of 217 patients were included in the final analysis (feasibility: 89.3%). Survival time of the higher OPS group (OPS ≥3) and the lower OPS group (OPS <3) was 10.0 (95% confidence interval (CI) 7.72–12.28) days and 32.0 (95% CI 25.44–38.56) days, respectively. There were significant differences between the 2 groups ( p < 0.001). Overall accuracy of OPS ≥3 for predicting survival less than three weeks was 71.0%. Conclusions: OPS was successfully validated using a prospective multicenter study in South Korea. It is a useful method to predict three-week survival of Korean inpatients with advanced cancer.